vs
Grocery Outlet Holding Corp.（GO）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Grocery Outlet Holding Corp.的季度营收约是Royalty Pharma plc的2.0倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -18.5%，领先52.9%），Grocery Outlet Holding Corp.同比增速更快（10.7% vs 4.8%），过去两年Grocery Outlet Holding Corp.的营收复合增速更高（8.3% vs 4.6%）
Grocery Outlet Holding Corp.是美国知名的折扣清仓零售企业，旗下所有门店均为超市，主打销售品牌厂商及自有品牌供应商的库存积压与清仓商品，价格优惠。目前该公司的门店已分布在美国加利福尼亚、俄勒冈、华盛顿、爱达荷等十余州。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GO vs RPRX — 直观对比
营收规模更大
GO
是对方的2.0倍
$622.0M
营收增速更快
GO
高出5.9%
4.8%
净利率更高
RPRX
高出52.9%
-18.5%
两年增速更快
GO
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $-224.9M | $214.2M |
| 毛利率 | 29.7% | — |
| 营业利润率 | — | 62.4% |
| 净利率 | -18.5% | 34.4% |
| 营收同比 | 10.7% | 4.8% |
| 净利润同比 | -669.9% | 2.9% |
| 每股收益（稀释后） | $-2.22 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GORPRX
| Q1 26 | $1.2B | — | ||
| Q4 25 | — | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.1B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M |
净利润GORPRX
| Q1 26 | $-224.9M | — | ||
| Q4 25 | — | $214.2M | ||
| Q3 25 | $11.6M | $288.2M | ||
| Q2 25 | $5.0M | $30.2M | ||
| Q1 25 | $-23.3M | $238.3M | ||
| Q4 24 | $2.3M | $208.2M | ||
| Q3 24 | $24.2M | $544.0M | ||
| Q2 24 | $14.0M | $102.0M |
毛利率GORPRX
| Q1 26 | 29.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 30.4% | — | ||
| Q2 25 | 30.6% | — | ||
| Q1 25 | 30.4% | — | ||
| Q4 24 | 29.5% | — | ||
| Q3 24 | 31.1% | — | ||
| Q2 24 | 30.9% | — |
营业利润率GORPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 62.4% | ||
| Q3 25 | 2.0% | 70.1% | ||
| Q2 25 | 1.1% | 36.3% | ||
| Q1 25 | -2.0% | 94.0% | ||
| Q4 24 | 1.0% | 60.9% | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 2.3% | 50.2% |
净利率GORPRX
| Q1 26 | -18.5% | — | ||
| Q4 25 | — | 34.4% | ||
| Q3 25 | 1.0% | 47.3% | ||
| Q2 25 | 0.4% | 5.2% | ||
| Q1 25 | -2.1% | 41.9% | ||
| Q4 24 | 0.2% | 35.1% | ||
| Q3 24 | 2.2% | 96.3% | ||
| Q2 24 | 1.2% | 19.0% |
每股收益（稀释后）GORPRX
| Q1 26 | $-2.22 | — | ||
| Q4 25 | — | $0.49 | ||
| Q3 25 | $0.12 | $0.67 | ||
| Q2 25 | $0.05 | $0.07 | ||
| Q1 25 | $-0.24 | $0.55 | ||
| Q4 24 | $0.03 | $0.46 | ||
| Q3 24 | $0.24 | $1.21 | ||
| Q2 24 | $0.14 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.6M | $618.7M |
| 总债务越低越好 | $15.0M | $9.0B |
| 股东权益账面价值 | $983.7M | $9.7B |
| 总资产 | $3.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.02× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GORPRX
| Q1 26 | $69.6M | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | $52.1M | $938.9M | ||
| Q2 25 | $55.2M | $631.9M | ||
| Q1 25 | $50.9M | $1.1B | ||
| Q4 24 | $62.8M | $929.0M | ||
| Q3 24 | $68.7M | $950.1M | ||
| Q2 24 | $67.1M | $1.8B |
总债务GORPRX
| Q1 26 | $15.0M | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | $500.3M | $8.9B | ||
| Q2 25 | $473.9M | $8.0B | ||
| Q1 25 | $475.7M | $7.6B | ||
| Q4 24 | $477.5M | $7.6B | ||
| Q3 24 | $429.3M | $7.6B | ||
| Q2 24 | $379.2M | $7.6B |
股东权益GORPRX
| Q1 26 | $983.7M | — | ||
| Q4 25 | — | $9.7B | ||
| Q3 25 | $1.2B | $9.6B | ||
| Q2 25 | $1.2B | $9.5B | ||
| Q1 25 | $1.2B | $9.8B | ||
| Q4 24 | $1.2B | $10.3B | ||
| Q3 24 | $1.2B | $10.3B | ||
| Q2 24 | $1.2B | $9.8B |
总资产GORPRX
| Q1 26 | $3.1B | — | ||
| Q4 25 | — | $19.6B | ||
| Q3 25 | $3.4B | $19.3B | ||
| Q2 25 | $3.3B | $18.3B | ||
| Q1 25 | $3.3B | $17.6B | ||
| Q4 24 | $3.2B | $18.2B | ||
| Q3 24 | $3.1B | $18.0B | ||
| Q2 24 | $3.1B | $17.7B |
负债/权益比GORPRX
| Q1 26 | 0.02× | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | 0.42× | 0.93× | ||
| Q2 25 | 0.40× | 0.84× | ||
| Q1 25 | 0.40× | 0.78× | ||
| Q4 24 | 0.40× | 0.74× | ||
| Q3 24 | 0.35× | 0.74× | ||
| Q2 24 | 0.31× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $222.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GORPRX
| Q1 26 | $222.1M | — | ||
| Q4 25 | — | $827.1M | ||
| Q3 25 | $17.3M | $702.6M | ||
| Q2 25 | $73.6M | $364.0M | ||
| Q1 25 | $58.9M | $596.1M | ||
| Q4 24 | $39.5M | $742.5M | ||
| Q3 24 | $23.0M | $703.6M | ||
| Q2 24 | $41.6M | $658.2M |
自由现金流GORPRX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-21.6M | — | ||
| Q2 25 | $14.4M | — | ||
| Q1 25 | $-1.5M | — | ||
| Q4 24 | $-19.6M | — | ||
| Q3 24 | $-19.3M | — | ||
| Q2 24 | $2.7M | — |
自由现金流率GORPRX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -1.8% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | -1.8% | — | ||
| Q3 24 | -1.7% | — | ||
| Q2 24 | 0.2% | — |
资本支出强度GORPRX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 5.0% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 3.4% | — |
现金转化率GORPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 3.86× | ||
| Q3 25 | 1.49× | 2.44× | ||
| Q2 25 | 14.84× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 17.09× | 3.57× | ||
| Q3 24 | 0.95× | 1.29× | ||
| Q2 24 | 2.97× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GO
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
